<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000467824">
  <TermName>5-HT3 receptor antagonist</TermName>
  <TermPronunciation>(… reh-SEP-ter an-TA-guh-nist)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A type of drug used to treat certain types of irritable bowel syndrome and relieve nausea and vomiting. It is a type of antiemetic. Also called 5-hydroxytryptamine 3 receptor antagonist and type 3 serotonin receptor antagonist.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000716782" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;5-HT3 receptor antagonist&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000716783" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;antagonista del receptor 5-HT3&quot;" language="es" id="_4"/>
  <SpanishTermName>antagonista del receptor 5-HT3</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Tipo de medicamento que se usa para tratar ciertos tipos de síndrome del colon irritable, y aliviar náuseas y vómitos. Es un tipo de antiemético. También se llama antagonista del receptor de 5-hidroxitriptamina 3 y antagonista del receptor de seratonina tipo 3.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2006-05-11</DateFirstPublished>
  <DateLastModified>2008-01-14</DateLastModified>
</GlossaryTerm>
